Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 543

1.

Clearance of hepatitis C virus is associated with early and potent but narrowly-directed, Envelope-specific antibodies.

Walker MR, Leung P, Eltahla AA, Underwood A, Abayasingam A, Brasher NA, Li H, Wu BR, Maher L, Luciani F, Lloyd AR, Bull RA.

Sci Rep. 2019 Sep 16;9(1):13300. doi: 10.1038/s41598-019-49454-w.

2.

Dependence of DNA looping on Escherichia coli culture density.

Peters JP, Rao VN, Becker NA, Maher LJ 3rd.

Int J Biochem Mol Biol. 2019 Aug 15;10(3):32-41. eCollection 2019.

3.

A conditional mouse model of complex II deficiency manifesting as Leigh-like syndrome.

Al Khazal F, Holte MN, Bolon B, White TA, LeBrasseur N, Maher LJ 3rd.

FASEB J. 2019 Aug 30:fj201802655RR. doi: 10.1096/fj.201802655RR. [Epub ahead of print]

PMID:
31469588
4.

Lithic technology, chronology, and marine shells from Wadi Aghar, southern Jordan, and Initial Upper Paleolithic behaviors in the southern inland Levant.

Kadowaki S, Tamura T, Sano K, Kurozumi T, Maher LA, Wakano JY, Omori T, Kida R, Hirose M, Massadeh S, Henry DO.

J Hum Evol. 2019 Aug 23;135:102646. doi: 10.1016/j.jhevol.2019.102646. [Epub ahead of print]

PMID:
31450172
5.

Author Correction: Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function.

Bailis W, Shyer JA, Zhao J, Canaveras JCG, Al Khazal FJ, Qu R, Steach HR, Bielecki P, Khan O, Jackson R, Kluger Y, Maher LJ 3rd, Rabinowitz J, Craft J, Flavell RA.

Nature. 2019 Sep;573(7773):E2. doi: 10.1038/s41586-019-1490-y.

PMID:
31447485
6.
7.

Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations.

Smestad JA, Maher LJ 3rd.

BMC Cancer. 2019 Jun 24;19(1):619. doi: 10.1186/s12885-019-5813-z.

8.

Who's that SMARTgirl? Reaching Cambodian Female Entertainment and Sex Workers with HIV Prevention Services.

Lee JY, Page K, Stein E, Evans JL, Sokunny M, Maly P, Sophal C, Ngak S, Maher L, Carrico AW.

AIDS Behav. 2019 Jun 22. doi: 10.1007/s10461-019-02532-6. [Epub ahead of print]

PMID:
31230177
9.

Transforming lives and empowering communities: evidence, harm reduction and a holistic approach to people who use drugs.

Southwell M, Shelly S, MacDonald V, Verster A, Maher L.

Curr Opin HIV AIDS. 2019 Sep;14(5):409-414. doi: 10.1097/COH.0000000000000566.

PMID:
31219890
10.

Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function.

Bailis W, Shyer JA, Zhao J, Canaveras JCG, Al Khazal FJ, Qu R, Steach HR, Bielecki P, Khan O, Jackson R, Kluger Y, Maher LJ 3rd, Rabinowitz J, Craft J, Flavell RA.

Nature. 2019 Jul;571(7765):403-407. doi: 10.1038/s41586-019-1311-3. Epub 2019 Jun 19. Erratum in: Nature. 2019 Sep;573(7773):E2.

PMID:
31217581
11.

Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.

Morris MD, Andrew E, Tan JY, Maher L, Hoff C, Darbes L, Page K.

PLoS One. 2019 May 31;14(5):e0217811. doi: 10.1371/journal.pone.0217811. eCollection 2019.

12.

Glial cells as therapeutic targets in progressive multiple sclerosis.

Wilbanks B, Maher LJ 3rd, Rodriguez M.

Expert Rev Neurother. 2019 Jun;19(6):481-494. doi: 10.1080/14737175.2019.1614443. Epub 2019 May 13.

PMID:
31081705
13.

Qualitative perspectives on the sustainability of sexual health continuous quality improvement in clinics serving remote Aboriginal communities in Australia.

Gunaratnam P, Schierhout G, Brands J, Maher L, Bailie R, Ward J, Guy R, Rumbold A, Ryder N, Fairley CK, Donovan B, Moore L, Kaldor J, Bell S.

BMJ Open. 2019 May 5;9(5):e026679. doi: 10.1136/bmjopen-2018-026679.

14.

Hepatitis C virus testing, liver disease assessment and direct-acting antiviral treatment uptake and outcomes in a service for people who are homeless in Sydney, Australia: The LiveRLife homelessness study.

Bajis S, Grebely J, Cooper L, Smith J, Owen G, Chudleigh A, Hajarizadeh B, Martinello M, Adey S, Read P, Gilliver R, Applegate T, Treloar C, Maher L, Dore GJ.

J Viral Hepat. 2019 Aug;26(8):969-979. doi: 10.1111/jvh.13112. Epub 2019 May 2.

PMID:
30980785
15.

Can a continuous quality improvement program create culturally safe emergency departments for Aboriginal people in Australia? A multiple baseline study.

Gadsden T, Wilson G, Totterdell J, Willis J, Gupta A, Chong A, Clarke A, Winters M, Donahue K, Posenelli S, Maher L, Stewart J, Gardiner H, Passmore E, Cashmore A, Milat A.

BMC Health Serv Res. 2019 Apr 11;19(1):222. doi: 10.1186/s12913-019-4049-6.

16.

HIV Pre-exposure Prophylaxis (PrEP) Uptake Among Gay and Bisexual Men in Australia and Factors Associated With the Nonuse of PrEP Among Eligible Men: Results From a Prospective Cohort Study.

Hammoud MA, Vaccher S, Jin F, Bourne A, Maher L, Holt M, Bavinton BR, Haire B, Degenhardt L, Grulich A, Prestage GP.

J Acquir Immune Defic Syndr. 2019 Jul 1;81(3):e73-e84. doi: 10.1097/QAI.0000000000002047.

PMID:
30973548
17.

Turning points, identity, and social capital: A meta-ethnography of methamphetamine recovery.

Brookfield S, Fitzgerald L, Selvey L, Maher L.

Int J Drug Policy. 2019 May;67:79-90. doi: 10.1016/j.drugpo.2019.02.002. Epub 2019 Apr 7. Review.

PMID:
30970290
18.

Optimization of a 40-mer Antimyelin DNA Aptamer Identifies a 20-mer with Enhanced Properties for Potential Multiple Sclerosis Therapy.

Wilbanks B, Smestad J, Heider RM, Warrington AE, Rodriguez M, Maher LJ 3rd.

Nucleic Acid Ther. 2019 Jun;29(3):126-135. doi: 10.1089/nat.2018.0776. Epub 2019 Mar 11.

19.

Genomic characterization of hepatitis C virus transmitted founder variants with deep sequencing.

Abayasingam A, Leung P, Eltahla A, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Cox AL, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd A, Rodrigo C; InC3 Study Group.

Infect Genet Evol. 2019 Jul;71:36-41. doi: 10.1016/j.meegid.2019.02.032. Epub 2019 Mar 8.

PMID:
30853512
20.

Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.

Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; InC3 Collaborative.

Clin Infect Dis. 2019 Feb 28. pii: ciz162. doi: 10.1093/cid/ciz162. [Epub ahead of print]

PMID:
30816419
21.

Estimating the number of people who inject drugs and syringe coverage in Australia, 2005-2016.

Kwon JA, Iversen J, Law M, Dolan K, Wand H, Maher L.

Drug Alcohol Depend. 2019 Apr 1;197:108-114. doi: 10.1016/j.drugalcdep.2018.11.033. Epub 2019 Feb 13.

PMID:
30802734
22.

Brief Report: Changes in Behavior After PrEP Initiation Among Australian Gay and Bisexual Men.

Prestage G, Maher L, Grulich A, Bourne A, Hammoud M, Vaccher S, Bavinton B, Holt M, Jin F.

J Acquir Immune Defic Syndr. 2019 May 1;81(1):52-56. doi: 10.1097/QAI.0000000000001976.

PMID:
30768489
23.

The Blind Men and the Elephant: Meta-Ethnography 30 Years On.

Brookfield S, Fitzgerald L, Selvey L, Maher L.

Qual Health Res. 2019 Sep;29(11):1674-1681. doi: 10.1177/1049732319826061. Epub 2019 Feb 9.

PMID:
30741098
24.

Evidence for a bind-then-bend mechanism for architectural DNA binding protein yNhp6A.

Sarangi MK, Zvoda V, Holte MN, Becker NA, Peters JP, Maher LJ, Ansari A.

Nucleic Acids Res. 2019 Apr 8;47(6):2871-2883. doi: 10.1093/nar/gkz022.

25.

Evaluating the cost-effectiveness of existing needle and syringe programmes in preventing hepatitis C transmission in people who inject drugs.

Sweeney S, Ward Z, Platt L, Guinness L, Hickman M, Hope V, Maher L, Iversen J, Hutchinson SJ, Smith J, Ayres R, Hainey I, Vickerman P.

Addiction. 2019 Mar;114(3):560-570. doi: 10.1111/add.14519. Epub 2019 Jan 23.

PMID:
30674091
26.

Cluster randomized stepped-wedge trial of a multi-level HIV prevention intervention to decrease amphetamine-type stimulants and sexual risk in Cambodian female entertainment and sex workers.

Page K, Carrico AW, Stein E, Evans J, Sokunny M, Maly P, Sophal C, Neak Y, Ngak S, McCulloch C, Maher L.

Drug Alcohol Depend. 2019 Mar 1;196:21-30. doi: 10.1016/j.drugalcdep.2018.11.029. Epub 2019 Jan 11.

PMID:
30659994
27.

Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.

Coupland H, White B, Bates A, Park JN, Iversen J, Maher L.

Drug Alcohol Rev. 2019 Feb;38(2):177-184. doi: 10.1111/dar.12895. Epub 2019 Jan 16.

PMID:
30652363
28.

Attitudes and Perceived Social Norms toward Drug Use among Gay and Bisexual Men in Australia.

Lea T, Hammoud M, Bourne A, Maher L, Jin F, Haire B, Bath N, Grierson J, Prestage G.

Subst Use Misuse. 2019;54(6):944-954. doi: 10.1080/10826084.2018.1552302. Epub 2019 Jan 16.

PMID:
30648480
29.

Structural interventions and social suffering: Responding to amphetamine-type stimulant use among female entertainment and sex workers in Cambodia.

Coupland H, Page K, Stein E, Carrico A, Evans J, Dixon T, Sokunny M, Phou M, Maher L.

Int J Drug Policy. 2019 Feb;64:70-78. doi: 10.1016/j.drugpo.2018.12.002. Epub 2018 Dec 21.

PMID:
30583088
30.

Genomic variability of within-host hepatitis C variants in acute infection.

Rodrigo C, Leung P, Lloyd AR, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Eltahla AA; InC3 Collaborative.

J Viral Hepat. 2019 Apr;26(4):476-484. doi: 10.1111/jvh.13051. Epub 2019 Jan 22.

PMID:
30578702
31.

Understanding the Determinants of BnAb Induction in Acute HCV Infection.

Underwood AP, Walker MR, Brasher NA, Eltahla AA, Maher L, Luciani F, Lloyd AR, Bull RA.

Viruses. 2018 Nov 21;10(11). pii: E659. doi: 10.3390/v10110659.

32.

What initiatives do healthcare leaders agree are needed for healthcare system improvement? Results of a modified-Delphi study.

Barson S, Gauld R, Gray J, Henriks G, Krause C, Lachman P, Maher L, Massoud MR, Mathias L, Wagner M, Villa L.

J Health Organ Manag. 2018 Nov 19;32(8):1002-1012. doi: 10.1108/JHOM-08-2017-0216. Epub 2018 Nov 22.

PMID:
30468416
33.

Single and double box HMGB proteins differentially destabilize nucleosomes.

McCauley MJ, Huo R, Becker N, Holte MN, Muthurajan UM, Rouzina I, Luger K, Maher LJ 3rd, Israeloff NE, Williams MC.

Nucleic Acids Res. 2019 Jan 25;47(2):666-678. doi: 10.1093/nar/gky1119.

34.

Alcohol Text Messages: A Developmental Study.

Robinson M, Wilkinson RB, Fletcher R, Bruno R, Baker AL, Maher L, Wroe J, Dunlop AJ.

Int J Ment Health Addict. 2018;16(5):1125-1139. doi: 10.1007/s11469-017-9835-y. Epub 2017 Nov 28.

35.

Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia.

Bajis S, Maher L, Treloar C, Hajarizadeh B, Lamoury FMJ, Mowat Y, Schulz M, Marshall AD, Cunningham EB, Cock V, Ezard N, Gorton C, Hayllar J, Smith J, Whelan M, Martinello M, Applegate TL, Dore GJ, Grebely J; LiveRLife Study Group.

Int J Drug Policy. 2018 Nov;61:23-30. doi: 10.1016/j.drugpo.2018.08.011. Epub 2018 Oct 25.

PMID:
30388566
36.

Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.

Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P.

Lancet Infect Dis. 2018 Dec;18(12):1397-1409. doi: 10.1016/S1473-3099(18)30469-9. Epub 2018 Oct 29.

37.

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.

Iversen J, Dore GJ, Catlett B, Cunningham P, Grebely J, Maher L.

J Hepatol. 2019 Jan;70(1):33-39. doi: 10.1016/j.jhep.2018.09.030. Epub 2018 Oct 25.

PMID:
30367897
38.

Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.

Guy RJ, Ward J, Causer LM, Natoli L, Badman SG, Tangey A, Hengel B, Wand H, Whiley D, Tabrizi SN, Shephard M, Fairley CK, Donovan B, Anderson DA, Regan DG, Maher L, Kaldor JM.

Lancet Infect Dis. 2018 Oct;18(10):1117-1126. doi: 10.1016/S1473-3099(18)30429-8.

PMID:
30303108
39.

Randomised study demonstrates sustained benefits of a pre-school intervention designed to improve nutrition and physical activity practices.

de Zwarte D, Kearney J, Corish CA, Glennon C, Maher L, Johnston Molloy C.

J Public Health (Oxf). 2018 Oct 3. doi: 10.1093/pubmed/fdy173. [Epub ahead of print]

PMID:
30281073
40.

Surface Plasmon Resonance Sensing on Naturally Derived Membranes: A Remyelination-Promoting Human Antibody Binds Myelin with Extraordinary Affinity.

Vala M, Jordan LR, Warrington AE, Maher LJ 3rd, Rodriguez M, Wittenberg NJ, Oh SH.

Anal Chem. 2018 Nov 6;90(21):12567-12573. doi: 10.1021/acs.analchem.8b02664. Epub 2018 Oct 15.

PMID:
30231202
41.

Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.

Boyd J, Collins AB, Mayer S, Maher L, Kerr T, McNeil R.

Addiction. 2018 Dec;113(12):2261-2270. doi: 10.1111/add.14417. Epub 2018 Sep 14.

PMID:
30211453
42.

Approaches for Determining DNA Persistence Length Using Atomic Force Microscopy.

Peters JP, Maher LJ 3rd.

Methods Mol Biol. 2018;1837:211-256. doi: 10.1007/978-1-4939-8675-0_13.

PMID:
30109614
43.

High-Resolution Characterization of DNA/Protein Complexes in Living Bacteria.

Becker NA, Peters JP, Maher LJ 3rd.

Methods Mol Biol. 2018;1837:95-115. doi: 10.1007/978-1-4939-8675-0_6.

PMID:
30109607
44.

Proportion and predictors of loss to follow-up in a longitudinal cohort study of female entertainment and sex workers in Cambodia.

Chhim S, Chhea C, Sopheab H, Mathers BM, Kaldor J, Evans JL, Stein ES, Carrico A, Muth S, Song N, Maher L, Page K.

Int J STD AIDS. 2018 Nov;29(13):1295-1304. doi: 10.1177/0956462418779471. Epub 2018 Jul 6.

45.

Health risk and health seeking behaviours among people who inject performance and image enhancing drugs who access needle syringe programs in Australia.

Van de Ven K, Maher L, Wand H, Memedovic S, Jackson E, Iversen J.

Drug Alcohol Rev. 2018 Nov;37(7):837-846. doi: 10.1111/dar.12831. Epub 2018 Jul 2.

PMID:
29968372
46.

The Participatory Zeitgeist: an explanatory theoretical model of change in an era of coproduction and codesign in healthcare improvement.

Palmer VJ, Weavell W, Callander R, Piper D, Richard L, Maher L, Boyd H, Herrman H, Furler J, Gunn J, Iedema R, Robert G.

Med Humanit. 2019 Sep;45(3):247-257. doi: 10.1136/medhum-2017-011398. Epub 2018 Jun 28.

PMID:
29954854
47.

Chromatin Succinylation Correlates with Active Gene Expression and Is Perturbed by Defective TCA Cycle Metabolism.

Smestad J, Erber L, Chen Y, Maher LJ 3rd.

iScience. 2018 Apr 27;2:63-75. doi: 10.1016/j.isci.2018.03.012.

48.

Bone Lesions of Sarcoidosis.

Maher LV.

J Clin Rheumatol. 2018 Apr 19. doi: 10.1097/RHU.0000000000000785. [Epub ahead of print] No abstract available.

PMID:
29794513
49.

Age-related prevalence and twelve-month incidence of illicit drug use in a cohort of Australian gay and bisexual men: Results from the Flux Study.

Jin F, Hammoud MA, Maher L, Degenhardt L, Bourne A, Lea T, Vaccher S, Grierson J, Haire B, Prestage GP.

Drug Alcohol Depend. 2018 Jul 1;188:175-179. doi: 10.1016/j.drugalcdep.2018.04.009. Epub 2018 May 12.

PMID:
29778770
50.

The impact of telephone follow up on adverse events for Aboriginal people with chronic disease in new South Wales, Australia: a retrospective cohort study.

Jayakody A, Passmore E, Oldmeadow C, Bryant J, Carey M, Simons E, Cashmore A, Maher L, Hennessey K, Bunfield J, Terare M, Milat A, Sanson-Fisher R.

Int J Equity Health. 2018 May 18;17(1):60. doi: 10.1186/s12939-018-0776-2.

Supplemental Content

Support Center